{
    "organizations": [],
    "uuid": "12ce17667bec6e7a0733f76caee537e6785235d5",
    "author": "",
    "url": "https://www.reuters.com/article/brief-hemogenyx-pharmaceuticals-collabor/brief-hemogenyx-pharmaceuticals-collaborates-with-us-biotechnology-firm-idUSFWN1QV070",
    "ord_in_thread": 0,
    "title": "BRIEF-Hemogenyx Pharmaceuticals Collaborates With US Biotechnology Firm",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 13, 2018 / 8:11 AM / in 11 minutes BRIEF-Hemogenyx Pharmaceuticals Collaborates With US Biotechnology Firm Reuters Staff 1 Min Read March 13 (Reuters) - Hemogenyx Pharmaceuticals Plc: * ENTERED INTO A COLLABORATION WITH MAJOR US BIOTECHNOLOGY COMPANY IN A DEAL WORTH UP TO APPROXIMATELY $250,000 FOR HEMOGENYXâ€‹ Source text for Eikon: Further company coverage:",
    "published": "2018-03-13T10:08:00.000+02:00",
    "crawled": "2018-03-13T10:27:12.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "minute",
        "pharmaceutical",
        "collaborates",
        "u",
        "biotechnology",
        "firm",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "hemogenyx",
        "pharmaceutical",
        "plc",
        "entered",
        "collaboration",
        "major",
        "u",
        "biotechnology",
        "company",
        "deal",
        "worth",
        "approximately",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}